Dr Agarwal's Health Care. Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 1,83,331 shares,. Its Average Traded Price (ATP) is ₹503.43, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 19 @ ₹508.40.
Dr Agarwal's Health Care. has an upper circuit limit of ₹610.05 and a lower circuit limit of ₹406.75. The total value traded stands at ₹9.23 CR, and the delivery percentage for the day is 75.67%.
The stock is currently traded with a market lot size of 1. Dr Agarwal's Health Care. also offers a dividend yield of 0%.
Dr Agarwal's Health Care Share Price Chart
Dr Agarwal's Health Care. Share Key Metrics
Volume
1.83 L
Market Cap
16115.42 CR
LTQ@LTP
19@508.40
ATP
503.43
Var Margin
13.89 %
Circuit Range
406.75-610.05
Delivery %
75.67 %
Value
9.23 CR
ASM/GSM
No
Market Lot
1
Dr Agarwal's Health Care. Resistance and Support
Pivot 508.45
Resistance
First Resistance
516.7
Second Resistance
525.05
Third Resistance
533.3
Support
First Support
500.1
Second Support
491.85
Third Support
483.5
Dr Agarwal's Health Care. Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-04 | Quarterly Results |
| 2026-05-21 | Audited Results |
| 2026-02-03 | Quarterly Results |
| 2025-10-30 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-28 | Audited Results |
| 2025-02-14 | Quarterly Results |
Dr Agarwal's Health Care. News
Dr. Agarwals Health Care Ltd - 544350 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Dr. Agarwal's Health Care's subsidiary, Dr. Agarwal's Eye Hospital Limited (AEHL), inaugurated the world's first Pinhole Pupilloplasty (PPP) Centre in Chennai. This new center utilizes a pioneering microsurgical technique to treat complex corneal disorders without requiring donor tissue.
Aug 27 2026 15:51:22
Dr. Agarwals Health Care Ltd - 544350 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dr. Agarwal's Health Care officials will participate in upcoming investor conferences, including the Jefferies India Forum and Kotak Healthcare Forum, in September 2026. The company confirmed no unpublished price-sensitive information will be discussed during these meetings.
Aug 25 2026 17:30:10
Dr. Agarwals Health Care Ltd - 544350 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Catalyst Trusteeship, acting as Onshore Security Agent, has created a new pledge over 7.54 million equity shares of Dr. Agarwal's Health Care. This increases the total encumbered shares to 15.47% of the company's capital, for a facility to Hyperion Investments Pte. Ltd.
Aug 25 2026 10:57:02
Dr. Agarwals Health Care Ltd - 544350 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Claymore Investments (Mauritius) Pte. Ltd., along with its PAC Arvon Investments Pte. Ltd., sold 1.59 crore equity shares of Dr. Agarwal's Health Care Limited, reducing their combined shareholding by 5.02% to 15.04%. The transaction was executed via the open market.
Aug 14 2026 14:42:58
Dr. Agarwals Health Care Ltd - 544350 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Hyperion Investments Pte. Ltd., a significant shareholder in Dr. Agarwal's Health Care, sold 2.41 crore shares. This disposal reduced its holding from 23.09% to 15.47% through open market transactions.
Aug 14 2026 11:55:30
Dr. Agarwals Health Care Ltd - 544350 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Invesco Mutual Fund has increased its aggregate holding in Dr. Agarwal's Health Care to 5.2125% of the paid-up share capital, up from 3.0240% previously. This stake was acquired through open market purchases, signaling increased institutional confidence.
Aug 14 2026 11:52:31
Dr. Agarwals Health Care Ltd - 544350 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Dr. Agarwal's Health Care reported that Catalyst Trusteeship Limited has released encumbrance on 31,698,303 equity shares, which is 10.00% of the company's total share capital. This reduces the total encumbered shares to 13.09%.
Aug 14 2026 11:47:36
Dr. Agarwals Health Care Ltd - 544350 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
ICICI Prudential Mutual Fund acquired 1.70 crore shares of Dr. Agarwal's Health Care on August 12, 2026. This acquisition increased their total stake to 5.36% of the company's paid-up capital.
Aug 14 2026 11:38:46
Dr Agarwal's Health Care. Management
| Name | Position |
|---|---|
| Thanikainathan Arumugam | Company Secretary & Compliance Officer |
| Adil Agarwal | Whole Time Director & Chief Executive Officer |
Dr Agarwal's Health Care. Similar Stocks
Eris Lifesciences Ltd.
1355.50
-1.10 (0.08%)
Onesource Specialty Pharma Ltd.
1592.20
50.30 (3.26%)
Poly Medicure Ltd.
1738.50
-9.20 (0.53%)
Cohance Lifesciences Ltd.
440.20
-5.10 (1.15%)
Jubilant Pharmova Ltd.
1025.20
-0.45 (0.04%)
Alembic Pharmaceuticals Ltd.
810.95
-5.45 (0.67%)
Vijaya Diagnostic Centre Ltd.
1502.00
3.20 (0.21%)
Concord Biotech Ltd.
1505.70
52.90 (3.64%)
Marksans Pharma Ltd.
329.40
-1.00 (0.30%)
Dr Agarwal's Health Care. FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in AGARWALEYE
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC
Or Download Choice FinX App
Invest in AGARWALEYE
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade